7569-58-6

Basic information

• Product Name: 3-CHLORO-4-METHOXYBENZENEACETONITRILE
• Synonyms: 3-CHLORO-4-METHOXYBENZENEACETONITRILE;3-Chloro-4-methoxyphenylacetonitrile
• CAS NO: 7569-58-6
• Molecular Formula: C₉H₈ClNO
• Molecular Weight: 181.62
• Product Categories: pharmacetical
• Mol File: 7569-58-6.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 298 °C at 760 mmHg
• Flash Point: 134 °C
• Appearance: /
• Density: 1.198 g/cm³
• Vapor Pressure: 0.00131mmHg at 25°C
• Refractive Index: 1.536
• CAS DataBase Reference: 3-CHLORO-4-METHOXYBENZENEACETONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-CHLORO-4-METHOXYBENZENEACETONITRILE(7569-58-6)
• EPA Substance Registry System: 3-CHLORO-4-METHOXYBENZENEACETONITRILE(7569-58-6)

Safety Data

• Hazardous Substances Data: 7569-58-6(Hazardous Substances Data)

Usage

General Description

3-Chloro-4-Methoxybenzeneacetonitrile is a chemical compound with the molecular formula C9H7ClNO. It is a white to light yellow crystalline powder that is commonly used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. 3-CHLORO-4-METHOXYBENZENEACETONITRILE is also used in the production of dyes, pigments, and other organic substances. It is known for its high purity and stability, making it a popular choice for chemical reactions and research purposes. Additionally, 3-Chloro-4-Methoxybenzeneacetonitrile is considered to be moderately toxic and should be handled with care to prevent any potential health hazards.

InChI:InChI=1/C9H8ClNO/c1-12-9-3-2-7(4-5-11)6-8(9)10/h2-3,6H,4H2,1H3

Upstream product

• 4903-09-7 3-chloro-4-methoxy-benzaldehyde 
• 38622-91-2 [(p-methylphenyl)sulfonylmethyl]isonitrile 
• 320407-92-9 4-(bromomethyl)-2-chloro-1-methoxybenzene 
• 766-51-8 2-Chloroanisole 
• 14503-45-8 3-chloro-4-methoxybenzyl alcohol 
• 104-47-2 p-methoxybenzylnitrile 
• 13719-57-8 3-chloro-4-methoxybenzyl chloride 
• 143-33-9 sodium cyanide 
• 151-50-8 potassium cyanide 

Downstream Products

• 13721-20-5 2-(3-chloro-4-methoxyphenyl)acetic acid 
• 59557-17-4 ethyl 3-chloro-4-methoxyphenylmethylimidate 
• 936728-03-9 1-(3-chloro-4-methoxyphenyl)cyclopropane-1-carboxylic acid 
• 13726-26-6 3-Chlor-4-methoxy-phenylacetylhomoveratrylamin 
• 7569-88-2 N-Formyl-<3-chlor-4-methoxy-β-phenaethylamin> 
• 20503-09-7 2-(2-hydroxy-4-methoxyphenyl)acetic acid 
• 6496-89-5 2,4-dimethoxyphenylacetic acid 
• 33697-81-3 (3-chloro-4-hydroxy-phenyl)-acetic acid 
• 90955-43-4 7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide 
• 115514-69-7 1-phenyl-6-chloro-7-methoxy-1,2,3,4-tetrahydroisoquinoline 
• 115514-70-0 1-phenyl-6-chloro-7-methoxy-N-methyl-1,2,3,4-tetrahydroisoquinoline 
• 115514-71-1 1-phenyl-6-chloro-7-hydroxy-N-methyl-1,2,3,4-tetrahydroisoquinoline 
• 115514-75-5 1-benzyl-6-chloro-7-methoxy-N-methyl-1,2,3,4-tetrahydroisoquinoline 
• 115514-76-6 1-benzyl-6-chloro-7-hydroxy-N-methyl-1,2,3,4-tetrahydroisoquinoline 

Relevant articles and documents

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

MODULATORS OF CFTR

Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"). The present invention also relates to methods of treating CFTR mediated diseases using compounds of the present invention.

Non-nucleoside reverse transcriptase inhibitors

The present invention provides for compounds useful for treating an HIV-1 infection, or preventing an HIV-1 infection, or treating AIDS or ARC. The compounds of the invention are of formula I wherein R1-R4 and Ar are as herein defined. Also disclosed in t